Announcements Trials
Browse Landscape

Status

Completed 1

Sponsor Class

NIH 1

Study Type

Observational 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Carcinoma, Hepatocellular 6Recurrence 2Hepatitis B 2Liver Neoplasms 1Liver Failure, Acute 1Fibrosis 1Colorectal Neoplasms 1

Interventions

Blood Specimen Collection 6Magnetic Resonance Spectroscopy 4Tenofovir 3Liver Transplantation 3Specimen Handling 2Sorafenib 2Simvastatin 2tremelimumab 1sonidegib 1sofosbuvir-velpatasvir drug combination 1peginterferon alfa-2a 1navitoclax 1maltodextrin 1hepatitis B hyperimmune globulin 1durvalumab 1contrast agent BR1 1bavituximab 1atezolizumab 1apixaban 1adefovir dipivoxil 1Viusid 1Vitamin D 1User-Centered Design 1Surveys and Questionnaires 1Sunitinib 1Spermine Synthase 1Sonazoid 1Sampling Studies 1Radiotherapy 1Radiofrequency Ablation 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Fibrosis × Lamivudine × Gastrointestinal × Clear all
NCT00059267 2024-11-15

Prevention of Recurrent Hepatitis B After Liver Transplantation

National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)

Completed
317 enrolled
Gastrointestinal

Fibrosis, Hepatitis B, Carcinoma, Hepatocellular, Liver Failure, Acute

Data powered by HemOnc (CC BY 4.0) Colophon âš¡